218 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

BHC

Bausch Health Companies
US$6.563.1%-20.3%US$2.3bUS$9.79PE-5.3xE95.1%n/a

ELAN

Elanco Animal Health
US$17.685.3%91.8%US$8.7bUS$19.11PS2xE91.6%n/a

SUPN

Supernus Pharmaceuticals
US$27.12-1.4%-19.1%US$1.5bUS$40.50PS2.5xE60.0%n/a

JAZZ

Jazz Pharmaceuticals
US$105.25-0.8%-18.0%US$6.6bUS$180.89PE20.1xE18.6%n/a

9926

Akeso
HK$44.0018.8%21.4%HK$38.1bHK$58.93PE17.4xE11.0%n/a

4540

Tsumura
JP¥3,950.002.1%41.3%JP¥299.9bJP¥5,150.00PE18xE16.2%3.4%

6600

SciClone Pharmaceuticals (Holdings)
HK$18.500.5%86.3%HK$11.2bHK$17.86PE9.3xE4.7%0%

A003850

Boryung
₩10,280.00-2.8%14.1%₩682.7b₩15,333.33PE13.1xE23.5%1.0%

2269

WuXi Biologics (Cayman)
HK$11.14-10.5%-74.9%HK$46.3bHK$26.86PE12.6xE14.1%n/a

TCON

TRACON Pharmaceuticals
US$1.28-14.1%-89.6%US$2.8mUS$30.50PE1.7xE50.0%n/a

EAPI

Euroapi
€3.610.3%-64.3%€342.4m€3.52PB0.4xE77.5%n/a

NVAX

Novavax
US$15.03-3.0%97.2%US$2.1bUS$21.60PS2.1xE64.3%n/a

300685

Amoy Diagnostics
CN¥18.40-1.2%-29.6%CN¥7.3bCN¥28.60PE27.1xE20.8%0.8%

A170900

Dong-A ST
₩60,400.00-0.7%9.8%₩525.5b₩80,957.52PB0.8xE65.2%1.1%

2877

China Shineway Pharmaceutical Group
HK$8.36-6.7%-2.5%HK$6.3bHK$14.05PE6xE14.5%6.9%

MLAB

Mesa Laboratories
US$95.70-14.3%-27.1%US$596.2mUS$130.00PE544.5xE108.3%0.7%

CL

Cresco Labs
CA$2.62-0.8%17.5%CA$1.1bCA$6.18PB1.3xE104.1%n/a

KZA

Kazia Therapeutics
AU$0.08-27.3%-17.5%AU$18.9mn/aPS34068.4xE49.6%n/a

PNT

POINT Biopharma Global
US$12.500.2%75.1%US$1.3bUS$12.50PE13.8xE9.2%n/a

512

Grand Pharmaceutical Group
HK$4.932.3%2.3%HK$17.3bn/aPE9.2xE13.9%5.3%

TRJ

Trajan Group Holdings
AU$0.93-4.6%-37.2%AU$141.6mAU$1.15PB1.1xE77.4%n/a

FTRE

Fortrea Holdings
US$25.39-0.6%n/aUS$2.2bUS$32.22PB1.4xE60.4%n/a

300122

Chongqing Zhifei Biological Products
CN¥32.80-1.2%-31.8%CN¥78.5bCN¥58.50PE10.5xE18.3%2.4%

600521

Zhejiang Huahai Pharmaceutical
CN¥17.34-0.9%-6.5%CN¥25.4bCN¥18.50PE27.4xE21.2%1.2%
Page 4 of 10
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.